Follow-up of testicular germ cell tumours;Suivi des tumeurs germinates du testicule

Progres en Urologie

Volumn 15, Issue 4, 2005, Pages 593-596

  Culine, Stéphane ^a,b   Michel, Frédéric ^a   Rocher, Laurence ^a   Mottet, Nicolas ^a   Davin, Jean Louis ^a  

^a Comité Tumeurs du Testicule du CCAFU ^*  (France)

^b Parc Euromédecine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLOW UP; HEALTH SURVEY; HUMAN; MALE; METASTASIS; NEOPLASM; PRACTICE GUIDELINE; REVIEW; SEMINOMA; TESTIS TUMOR; TIME;

FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; POPULATION SURVEILLANCE; SEMINOMA; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 27644433081     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. BANIEL J., FOSTER R.S., GONIN R., MESSEMER J.E., DONOHUE J.P., EINHORN L.H. : Late relapse of testicular cancer. J. Clin. Oncol., 1995 ; 13: 1170-1176.
2. DE SANTIS M., BECHERER A., BOKEMEYER C., STOIBER F., OECHSLE K., SELLNER F., LANG A., KLETTER K., DOHMEN B.M., DITTRICH C., PONT J. : 2-18 fluoro-deoxy-D-glucose positon Emission Tomography is a reliable predictor for Viable tumor in postchemotherapy seminoma : an update of the prospective multicentric SEMPET trials. J. Clin. Oncol., 2004 ; 22 : 1034-1039.
3. DEARNAKEY D.P., HUDDART R.A., HORWICH A. : Managing testicular cancer. BMJ, 2001 ; 322 : 1583-1588.
4. GERL A., CLEMM C., SCHMELLER N., HENTRICH M., LAMERZ R., WILMANNS W. : Late relapse pf germ cell tumors after cisplatin-based chemotherapy. Ann. Oncol., 1997 ; 8 : 41-47.
5. GIETEMA J.A., MEINARDI M.T., SLEIFER D.T., HOEKSTRA H.J., VAN DER GRAAF W.T. : Routine chest X-rays have no additional value in the detection of relapse during routine follow up of patients treated with chemotherapy for disseminated non-seminomatous testicular cancer. Ann. Oncol., 2002 ; 13 : 1616-1620.
6. JONES W.G., FOSSA S.D., MEAD G.M., ROBERTS J.T., SOKAL M., HORWICH A., STENNING S.P. : Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma : a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942. J. Clin. Oncol., 2005 ; 20 : 1200-1208.
7. MCCAFFREY J.A., BAJORIN D.F., MOTZER R.J. : Risk assessment for metastatic testis cancer. Urol. Clin. North Amer., 1998 ; 25 : 3389-3395,
8. MOTTET N., AVANCES C., BASTIDE C., CULINE S., IBORRA F., KOURI G., LE SOURD A., MICHEL F., ROCHER L. : Tumeurs du testicule : recommandations Prog. Urol., 2004 ; 14 : 891-901.
9. OLIVER R.T. : Atrophy, hormones, genes and viruses in aetiology germ cell tumours. Cancer Surv. 1990 ; 9 : 263-286.
10. SCHMOLL H.J., SOUCHON R., KREGE S., ALBERS P., BEYER J., KOLLMANNSBERGER C., FOSSA S.D., SKAKKEBAEK N.E., DE WIT R., FIZAZI K., DROZ J.P., PIZZOCARO G., DAUGAARD G., DE MULDER P.H., HORWICH A., OLIVER T., HUDDART R., ROSTI G., PAZ ARES L., PONT O., HARTMANN J.T., AASS N., ALGABA F., BAMBERG M., BODROGI I., BOKEMEYER C., CLASSEN J., CLEMM S., CULINE S., DE WIT M., DERIGS H.G., DIECKMANN K.P., FLASSHOVE M., GARCIA DEL MURO X., GERL A., GERMA-LLUCH J.R., HARTMANN M., HEIDENREICH A., HOELTL W., JOFFE J., JONES W., KAISER G., KLEPP O., KLIESCH S., KISBENEDEK L., KOEHRMANN K.U., KUCZYK M., LAGUNA M.P., LEIVA O., LOY V., MASON M.D., MEAD G.M., MUELLER R.P., NICOLAI N., OOSTERHOF G.O., POTTEK T., RICK O., SCHMIDBERGER H., SEDLMAYER F., SIEGERT W., STUDER U., TJULANDIN S., VON DER MAASE H., WALZ P., WEINKNECHT S., WEISSBACH L., WINTER E., WITTEKIND C. : European consensus on diagnostic and treatment of germ cell cancer. A report of the European germ cell cancer consensus group (EGCCCG). Annals Oncology, 2004 ; 15 : 1377-1399.